← Back to directory

Róbert Hermann

Researcher Next ID · RN-038290

Researcher · Biochemistry, Genetics and Molecular Biology

Oslo University Hospital

Oslo, Norway

Accepting doctoral researchersFunding unknown
Works count
520
Citation count
20,979
H-index
65
i10-index
224

Research interests

Biochemistry, Genetics and Molecular Biology
Mathematics
Medicine
Physics and Astronomy
Diabetes and associated disorders
Nonlinear Waves and Solitons
Advanced Topics in Algebra
Pancreatic function and diabetes
Asthma and respiratory diseases

Publications

  • Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30863-0

  • Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

    The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30152-4

  • Relative predispositional effects of HLA class II DRB1‐DQB1 haplotypes and genotypes on type 1 diabetes: a meta‐analysis

    Tissue Antigens · 2007 · https://doi.org/10.1111/j.1399-0039.2007.00867.x

Current projects

    No projects listed.